Article
Evidence for genetic heterogeneity in malignant hyperthermia susceptibility.
Genomics - 1 Nov 1991
Levitt R C, Nouri N, Jedlicka A E, McKusick V A, Marks A R, Shutack J G, Fletcher J E, Rosenberg H, Meyers D A
Abstract excerpt
Malignant hyperthermia susceptibility (MHS) is a clinically heterogeneous pharmacogenetic disorder characterized by accelerated metabolism, hyperthermia, and frequently muscle rigidity. MHS is elicited by all commonly used potent inhalation anesthetics and depolarizing neuromuscular blockers and remains an important cause of death due to anesthesia. Recent linkage studies suggest a single genetic locus for this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
